skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 31  for All Library Resources

Results 1 2 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Emerging concepts in the science of vaccine adjuvants
Material Type:
Article
Add to My Research

Emerging concepts in the science of vaccine adjuvants

Nature reviews. Drug discovery, 2021-06, Vol.20 (6), p.454-475 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Springer Nature Limited 2021. ;Springer Nature Limited 2021 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/s41573-021-00163-y ;PMID: 33824489

Full text available

2
Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine
Material Type:
Article
Add to My Research

Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine

Nature immunology, 2022-04, Vol.23 (4), p.543-555 [Peer Reviewed Journal]

2022. The Author(s), under exclusive licence to Springer Nature America, Inc. ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2022. ;ISSN: 1529-2908 ;EISSN: 1529-2916 ;DOI: 10.1038/s41590-022-01163-9 ;PMID: 35288714

Full text available

3
A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice
Material Type:
Article
Add to My Research

A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice

Nature communications, 2022-01, Vol.13 (1), p.549-549, Article 549 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-022-28197-9 ;PMID: 35087093

Full text available

4
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
Material Type:
Article
Add to My Research

A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates

Nature communications, 2023-04, Vol.14 (1), p.2149-2149, Article 2149 [Peer Reviewed Journal]

2023. The Author(s). ;The Author(s) 2023. corrected publication 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-023-37417-9 ;PMID: 37069151

Full text available

5
Durability of immune responses to mRNA booster vaccination against COVID-19
Material Type:
Article
Add to My Research

Durability of immune responses to mRNA booster vaccination against COVID-19

The Journal of clinical investigation, 2023-05, Vol.133 (10), p.1-10 [Peer Reviewed Journal]

COPYRIGHT 2023 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation May 2023 ;2023 Arunachalam et al. 2023 Arunachalam et al. ;ISSN: 1558-8238 ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/JCI167955 ;PMID: 36951954

Full text available

6
The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection
Material Type:
Article
Add to My Research

The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection

PLoS pathogens, 2021-02, Vol.17 (2), p.e1009257-e1009257 [Peer Reviewed Journal]

2021 Charles et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Charles et al 2021 Charles et al ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/JOURNAL.PPAT.1009257 ;PMID: 33556148

Full text available

7
Author Correction: A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
Material Type:
Article
Add to My Research

Author Correction: A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates

Nature communications, 2023-10, Vol.14 (1), p.6211-6211, Article 6211 [Peer Reviewed Journal]

The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Springer Nature Limited 2023 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-023-42061-4 ;PMID: 37798288

Full text available

8
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice
Material Type:
Article
Add to My Research

Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice

npj vaccines, 2022-05, Vol.7 (1), p.55-55, Article 55 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2059-0105 ;EISSN: 2059-0105 ;DOI: 10.1038/s41541-022-00472-2 ;PMID: 35606518

Full text available

9
Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study
Material Type:
Article
Add to My Research

Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study

eLife, 2022-10, Vol.11 [Peer Reviewed Journal]

2022, Hu et al. ;2022, Hu et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022, Hu et al 2022 Hu et al ;ISSN: 2050-084X ;EISSN: 2050-084X ;DOI: 10.7554/elife.77943 ;PMID: 36239699

Full text available

10
Immune responses to SARS-CoV-2 in the lung
Material Type:
Article
Add to My Research

Immune responses to SARS-CoV-2 in the lung

Thorax, 2021-10, Vol.76 (10), p.961-961 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage ;ISSN: 0040-6376 ;EISSN: 1468-3296 ;DOI: 10.1136/thoraxjnl-2021-217231 ;PMID: 34088785

Full text available

11
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
Material Type:
Article
Add to My Research

Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans

Science, 2020-09, Vol.369 (6508) [Peer Reviewed Journal]

2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abc6261

Digital Resources/Online E-Resources

12
Systems vaccinology of the BNT162b2 mRNA vaccine in humans
Material Type:
Article
Add to My Research

Systems vaccinology of the BNT162b2 mRNA vaccine in humans

Nature (London), 2021-08, Vol.596 (7872), p.410-416 [Peer Reviewed Journal]

2021. The Author(s), under exclusive licence to Springer Nature Limited. ;COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Aug 19, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03791-x ;PMID: 34252919

Full text available

13
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination
Material Type:
Article
Add to My Research

Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination

Cell, 2022-03, Vol.185 (6), p.1025-1040.e14 [Peer Reviewed Journal]

2022 The Authors ;Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved. ;2022 The Authors 2022 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2022.01.018 ;PMID: 35148837

Full text available

14
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Material Type:
Article
Add to My Research

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

Cell, 2021-10, Vol.184 (21), p.5432-5447.e16 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.09.015 ;PMID: 34619077

Full text available

15
T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers
Material Type:
Article
Add to My Research

T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers

Nature medicine, 2020-06, Vol.26 (6), p.932-940 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-020-0858-8 ;PMID: 32393800

Full text available

16
Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia
Material Type:
Article
Add to My Research

Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia

Cell host & microbe, 2021-12, Vol.29 (12), p.1738-1743.e4 [Peer Reviewed Journal]

2021 The Authors ;Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved. ;2021 The Authors 2021 ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2021.11.004 ;PMID: 34861167

Full text available

17
Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8+ T cell responses post SARS-CoV-2 infection
Material Type:
Article
Add to My Research

Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8+ T cell responses post SARS-CoV-2 infection

Immunity (Cambridge, Mass.), 2023-04, Vol.56 (4), p.864-878.e4 [Peer Reviewed Journal]

2023 The Authors ;Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. ;ISSN: 1074-7613 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2023.03.005 ;PMID: 36996809

Full text available

18
PTAP motif duplication in the p6 Gag protein confers a replication advantage on HIV-1 subtype C
Material Type:
Article
Add to My Research

PTAP motif duplication in the p6 Gag protein confers a replication advantage on HIV-1 subtype C

The Journal of biological chemistry, 2018-07, Vol.293 (30), p.11687-11708 [Peer Reviewed Journal]

2018 ;ISSN: 0021-9258 ;EISSN: 1083-351X ;DOI: 10.1074/jbc.M117.815829 ;PMID: 29773649

Full text available

19
Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates
Material Type:
Article
Add to My Research

Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates

Cellular & molecular immunology, 2022-02, Vol.19 (2), p.222-233 [Peer Reviewed Journal]

2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1672-7681 ;EISSN: 2042-0226 ;DOI: 10.1038/s41423-021-00809-2 ;PMID: 34983950

Full text available

20
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice
Material Type:
Article
Add to My Research

Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice

Cell Reports, 2022-08, Vol.40 (9), p.111299-111299, Article 111299 [Peer Reviewed Journal]

2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2022 The Author(s) 2022 ;ISSN: 2211-1247 ;EISSN: 2211-1247 ;DOI: 10.1016/j.celrep.2022.111299 ;PMID: 35988541

Digital Resources/Online E-Resources

Results 1 - 20 of 31  for All Library Resources

Results 1 2 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (24)

Refine My Results

Creation Date 

From To
  1. Before 2016  (1)
  2. 2016 To 2017  (1)
  3. 2018 To 2019  (1)
  4. 2020 To 2021  (13)
  5. After 2021  (16)
  6. More options open sub menu

Resource Type 

  1. Articles  (30)
  2. Patents  (1)
  3. More options open sub menu

Language 

  1. Japanese  (3)
  2. French  (1)
  3. More options open sub menu

Searching Remote Databases, Please Wait